Evidence map›Paper›PMID 34663824›Full record

ArticleScientific reports2021

Synthesis and release behavior of layered double hydroxides-carbamazepine composites.

Ma F Peralta, S N Mendieta, I R Scolari, G E Granero, M E Crivello

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ma F PeraltaCentro de Investigación y Tecnología Química - CONICET - Universidad Tecnológica Nacional, Regional Córdoba, Maestro López Esq. Cruz Roja Argentina, S/N, X5016ZAA, Córdoba, Argentina.
S N MendietaCentro de Investigación y Tecnología Química - CONICET - Universidad Tecnológica Nacional, Regional Córdoba, Maestro López Esq. Cruz Roja Argentina, S/N, X5016ZAA, Córdoba, Argentina. smendieta@frc.utn.edu.ar.
I R ScolariUnidad de Investigación y Desarrollo en Tecnología Farmacéutica - CONICET - Universidad Nacional de Córdoba, Córdoba, Argentina.
G E GraneroUnidad de Investigación y Desarrollo en Tecnología Farmacéutica - CONICET - Universidad Nacional de Córdoba, Córdoba, Argentina.
M E CrivelloCentro de Investigación y Tecnología Química - CONICET - Universidad Tecnológica Nacional, Regional Córdoba, Maestro López Esq. Cruz Roja Argentina, S/N, X5016ZAA, Córdoba, Argentina. mcrivello@frc.utn.edu.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad Nacional de Córdoba · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbamazepine (CBZ) was incorporated into layered double hydroxides (LDH) to be used as a controlled drug system in solid tumors. CBZ has a formal charge of zero, so its incorporation in the anionic clay implies a challenge. Aiming to overcome this problem, CBZ was loaded into LDH with sodium cholate (SC), a surfactant with negative charge and, for comparison, without SC by the reconstruction method. Surprisingly, it was found that both resultant nanocomposites had similar CBZ encapsulation efficiency, around 75%, and the LDH-CBZ system without SC showed a better performance in relation to the release kinetics of CBZ in simulated body fluid (pH 7.4) and acetate buffer simulating the cellular cytoplasm (pH 4.8) than the system with SC. The CBZ dimensions were measured with Chem3D and, according to the basal spacing obtained from X-ray patterns, it can be arranged in the LDH-CBZ system as a monolayer with the long axis parallel to the LDH layers. Fourier transform infrared spectroscopy and solid state NMR measurements confirmed the presence of the drug, and thermogravimetric analyses showed an enhanced thermal stability for CBZ. These results have interesting implications since they increase the spectrum of LDH application as a controlled drug system to a large number of nonionic drugs, without the addition of other components.

Identifiers

PMID34663824
PMCPMC8523521
OpenAlexW3114254891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.